Living Legend Paul Corris reflects on a career that shaped global lung transplantation and pulmonary hypertension care, sharing his insights and experiences with Patricia Thistlethwaite and Nolan Winicki.
Join us for the first, Women's Health Task Force, webinar of 2026, exploring how biological sex influences pulmonary arterial hypertension (PAH) and respiratory disease.
Experts and advocates explore the genetics, biology, and clinical management of TBX4 syndrome, bridging discoveries from bench to bedside to advance understanding and care.
Join us in London on 2 June 2026 for a focused PVRI Symposium exploring how advances in genetics are shaping present and future therapies in PAH. Save the date and be part of the conversation driving the next phase of innovation.
Living Legend Marlene Rabinovitch shares the discoveries that transformed our understanding of pulmonary vascular disease and reflects on a career dedicated to advancing science and mentoring the next generation.
Join us to explore how imaging supports the diagnosis and management of PAH, across modalities including CT, MRI, echocardiography, and radiographs. Hear from global experts as they share practical insights into applying these tools in real-world clinical settings.
The PVRI Latin America Task Force is delighted to announce the 6th Paediatric and 3rd Adult Latin American Symposium on Pulmonary Hypertension, taking place in Lima, Peru, on 25–26 September 2026.
Building on the success of the 2024 symposium in São Paulo, this meeting continues to unite paediatric and adult specialists from across the region to share the latest advances in pulmonary hypertension (PH) research, diagnosis, and care.
The Leh Symposium, since 2010, has focused on pulmonary vascular diseases associated with low and high altitudes. This biennial conference offers a dynamic scientific program, bolstering clinical research, therapeutics, and global awareness for preventive health initiatives. We welcome our esteemed participants' contributions.
